Showing results (241-250 of 302) with videos related to
Sort By:
Pageof 31
Practical Radiation Oncology|June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local controlJennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.Annals of Surgical Oncology|August 3, 2020
Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After ChemoradiationEdward Christopher Dee, Morgan E Freret, Nora Horick, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 31, 2019
Clinical impact of PET/MR in treated colorectal cancer patientsBarbara J Amorim, Theodore S Hong, Lawrence S Blaszkowsky, et al.Cancer|February 7, 2014
Mutational analysis and clinical correlation of metastatic colorectal cancerAndrea L Russo, Darrell R Borger, Jackie Szymonifka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated dailyJoseph P Eder, Jeffrey G Supko, Jeffrey W Clark, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic CancerYves Boucher, Jessica M Posada, Sonu Subudhi, et al.JAMA Oncology|May 26, 2018
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.Journal for Immunotherapy of Cancer|October 13, 2020
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumorsAlbiruni Ra Razak, James M Cleary, Victor Moreno, et al.Practical Radiation Oncology|June 26, 2018
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasisSusan G R McDuff, Kyla A Remillard, Hui Zheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomasEunice L Kwak, Janusz Jankowski, Sarah P Thayer, et al.Pageof 31